Synera

Active Ingredient(s): Lidocaine + Tetracaine
FDA Approved: * June 23, 2005
Pharm Company: * ENDO PHARMS
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Synera Overview

A transdermal analgesic or pain relief patch is a medicated adhesive patch used to relieve minor to severe pain. There are two primary types of analgesic patches: patches containing counterirritants, which are used to treat mild to moderate pain, and patches containing fentanyl, a narcotic used to relieve moderate to severe pain in opioid-tolerant patients. Contents 1 Counterirritant patches 2 Fentanyl patches 3 See also 4 References Counterirritant patches Counterirritant patches...

Read more Synera Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Transdermal_analgesic_patch

Recent Synera Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lidocaine + Tetracaine
  • Cream: 7% + 7%
  • Patch: 70mg + 70mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Synera: (2 results)

Sorted by National Drug Code
  • 10885-002 Synera Cutaneous Patch by Galen Us Incorporated
  • 43469-864 Synera Cutaneous Patch by Zars Pharma, Inc.

Drugs with one or more similar ingredients: (33 results)